Novo Nordisk discovers and develops innovative medicines and makes them accessible to patients throughout the world. Nearly a century of innovation and leadership has led to the development of a comprehensive portfolio of products and delivery systems for diabetes care, as well as in other therapeutic areas where the company can make a difference. Novo Nordisk, Inc., is the US affiliate of Novo Nordisk A/S. We are one of the world’s leading diabetes care companies. Our US headquarters are located in Plainsboro, NJ, and the Novo Nordisk US business presence stretches from coast to coast -- from an insulin manufacturing plant in North Carolina to the Novo Nordisk Research Center in Seattle, WA.
Access each of our location pages below to read more about our sites within the U.S. and learn more about our company’s History.
DFP helps support Novo Nordisk as a leader in diabetes by providing a complete product portfolio of insulin and GLP-1 products.
DAPI will support Novo Nordisk in production and engineering.